- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06939790
Digital Cognitive-behavioral Therapy for Insomnia: a Randomized Controlled Trial (DCBT-I)
May 13, 2025 updated by: Luigi Ferini Strambi, IRCCS San Raffaele
Digital Cognitive-behavioral Therapy for Insomnia: a Randomized Controlled Trial to Improve Cost-effectiveness and Treatment Outcomes
The study investigates whether online Cognitive-Behavioral Therapy for insomnia is as effective as the standard in-person group treatment, using clinical and sleep-related outcomes in adult patients.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
This study aims to evaluate the effectiveness of digital Cognitive Behavioral Therapy for Insomnia (dCBT-I) in Italian, comparing it to the traditional face-to-face group-based CBT-I.
Sixty adults with chronic insomnia will be randomized to one of the two interventions, with assessments conducted pre- and post-treatment through validated questionnaires and objective sleep monitoring.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Luigi Ferini Strambi, MD
- Phone Number: +390226433363 +390226433363
- Email: ferinistrambi.luigi@hsr.it
Study Contact Backup
- Name: Luigi Strambi, MD
- Phone Number: +390226433363 +390226433363
- Email: ferinistrambi.luigi@hsr.it
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of chronic insomnia Individuals aged 18 to 75 years Signed informed consent form (ICF) prior to study participation
Exclusion Criteria:
- Diagnosis of comorbid sleep disorder (e.g. obstructive sleep apnea) Diagnosis of mental disorder in comorbidity Physical problems that may alter and dysregulate sleep Pregnancy and breastfeeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Digital Cognitive-Behavioral Therapy for Insomnia (dCBT-I)
The digital CBT-I (dCBT-I) is a self-guided online program replicating the structure and content of standard face-to-face CBT-I, aiming to offer a more accessible treatment for chronic insomnia.
It includes video lessons, interactive exercises, and relaxation techniques, with core components such as sleep education, sleep restriction, stimulus control and cognitive restructuring.
Supervision is provided through periodic check-ins.
|
The digital CBT-I (dCBT-I) is a self-guided online program replicating the structure and content of standard face-to-face CBT-I, aiming to offer a more accessible treatment for chronic insomnia.
It includes video lessons, interactive exercises, and relaxation techniques, with core components such as sleep education, sleep restriction, stimulus control and cognitive restructuring.
Supervision is provided through periodic check-ins.
|
|
Active Comparator: standard face-to-face group-based Cognitive-Behavioral Therapy for Insomnia (CBT-I)
The control group will receive standard face-to-face group-based CBT-I, the current gold-standard treatment for chronic insomnia.
Delivered by trained professionals, the intervention includes seven structured sessions covering core components such as sleep education, sleep restriction, stimulus control cognitive restructuring, and relaxation techniques.
Sessions last about 90 minutes and aim to improve sleep quality through evidence-based strategies.
|
The control group will receive standard face-to-face group-based CBT-I, the current gold-standard treatment for chronic insomnia.
Delivered by trained professionals, the intervention includes seven structured sessions covering core components such as sleep education, sleep restriction, stimulus control, cognitive restructuring, and relaxation techniques.
Sessions last about 90 minutes and aim to improve sleep quality through evidence-based strategies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To assess whether the benefits of dCBT-I are comparable with CBT-I treatment in standard group mode
Time Frame: Change from baseline to post-treatment (2 months)
|
Comparison at Insomnia Severity Index (ISI) questionnaire between the two groups evaluated at baseline and post-treatment.
|
Change from baseline to post-treatment (2 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2028
Study Registration Dates
First Submitted
April 15, 2025
First Submitted That Met QC Criteria
April 15, 2025
First Posted (Actual)
April 23, 2025
Study Record Updates
Last Update Posted (Actual)
May 16, 2025
Last Update Submitted That Met QC Criteria
May 13, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CET 129-2025 (Other Identifier: CET Lombardia 1)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteRecruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
Shanghai Haiyan Pharmaceutical Technology Co.,...Completed
-
Leiden UniversityBioClock Consortium; Caring UniveristiesCompleted
-
National Science Council, TaiwanCompleted
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
Clinical Trials on Digital Cognitive-Behavioral Therapy for Insomnia (dCBT-I)
-
WELT corpNot yet recruiting
-
Norwegian University of Science and TechnologyCompletedInsomnia | Pain, ChronicNorway
-
SRI InternationalStanford UniversityNot yet recruitingInsomnia | Menopause Related Conditions
-
Massachusetts General HospitalNational Institute on Aging (NIA)RecruitingInsomnia | Postoperative Delirium | Delayed Neurocognitive Recovery | Postoperative Neurocognitive DisorderUnited States
-
Henry Ford Health SystemUniversity of Michigan; Big Health Inc.CompletedMajor Depressive Disorder | Rumination | Insomnia, PrimaryUnited States
-
McGill UniversitySleepioTerminatedInsomnia Disorder | HIV - Human Immunodeficiency VirusCanada
-
St. Olavs HospitalUniversity of California, Berkeley; Norwegian University of Science and Technology and other collaboratorsCompleted
-
MICHAEL A GRANDNERUniversity of PennsylvaniaTerminatedSleep Initiation and Maintenance Disorders | Suicidal IdeationUnited States
-
St. Olavs HospitalActive, not recruitingMultiple Sclerosis | InsomniaNorway
-
University College DublinIrish Cancer Society; Big Health Ltd.; Research Electronic Data Capture (REDCap)Not yet recruiting